Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Ixekizumab (Anti-CTLA-8 / IL-17a) For research use only.
Not for use in humans.

Ixekizumab (Anti-CTLA-8 / IL-17a)

Synonyms: LY2439821

Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.

Ixekizumab (Anti-CTLA-8 / IL-17a)

Purity & Quality Control

Batch: A286201 Purity: 99% Protein concentration: 4.01mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.

Product Details

CAS No. 1143503-69-8
Molecular Weight 146.44
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ixekizumab (Anti-CTLA-8 / IL-17a) | Ixekizumab (Anti-CTLA-8 / IL-17a) supplier | purchase Ixekizumab (Anti-CTLA-8 / IL-17a) | Ixekizumab (Anti-CTLA-8 / IL-17a) cost | Ixekizumab (Anti-CTLA-8 / IL-17a) manufacturer | order Ixekizumab (Anti-CTLA-8 / IL-17a) | Ixekizumab (Anti-CTLA-8 / IL-17a) distributor